<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Korean J Hepatol via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Korean J Hepatol' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Korean+J+Hepatol&t=Korean+J+Hepatol&s=Search&f=source]]></link>
        <lastBuildDate>Sat, 30 Jan 2010 14:29:09 +0100</lastBuildDate>
        <item>
            <title>[Transient elastography, true or false?]</title>
            <link>http://www.medworm.com/index.php?rid=3127041&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037261%26dopt%3DAbstract</link>
            <description>Authors: Seo YS
    
    PMID: 20037261 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127041</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127041</guid>        </item>
        <item>
            <title>[Epidemiology and clinical features of acute hepatitis A: from the domestic perspective.]</title>
            <link>http://www.medworm.com/index.php?rid=3127040&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037262%26dopt%3DAbstract</link>
            <description>Authors: Jung YK, Kim JH
    Acute viral hepatitis A has recently become a major public health problem in Korea, and the incidence of symptomatic hepatitis A is growing rapidly. With improvements in socioeconomic conditions and environmental hygiene, the chances of exposure to hepatitis A virus (HAV) during childhood have decreased and, in turn, the proportion of young adults with positive anti-HAV has significantly decreased. This has led to the incidence of symptomatic acute hepatitis A increasing since the late 1990s. The incidence of serious complications including fulminant hepatic failure and acute kidney injury has also showed an increasing trend. Variation of the genotype of virus isolated from recent hepatitis A patients suggests an inflow of the hepatitis virus from other countri...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127040</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127040</guid>        </item>
        <item>
            <title>[Clinical efficacy of entecavir therapy and factors associated with treatment response in naive chronic hepatitis B patients.]</title>
            <link>http://www.medworm.com/index.php?rid=3127039&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037263%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Entecavir induced excellent biochemical and virologic responses in naive CHB patients. EVR was an independent factor for predicting HBV PCR negativity and HBeAg loss.
    PMID: 20037263 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127039</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127039</guid>        </item>
        <item>
            <title>[Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease.]</title>
            <link>http://www.medworm.com/index.php?rid=3127038&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037264%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: All noninvasive serum markers evaluated in this study were useful for predicting significant or extensive liver fibrosis in chronic viral liver diseases. In particular, APRI was most useful for the prediction of significant fibrosis, and CDS was most useful for the prediction of extensive fibrosis.
    PMID: 20037264 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127038</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127038</guid>        </item>
        <item>
            <title>[Factors associated with liver stiffness in chronic liver disease.]</title>
            <link>http://www.medworm.com/index.php?rid=3127037&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037265%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Liver stiffness as measured by transient elastography is associated with the grade of necroinflammatory activity and the stage of fibrosis, irrespective of serum ALT levels.
    PMID: 20037265 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127037</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127037</guid>        </item>
        <item>
            <title>[Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm.]</title>
            <link>http://www.medworm.com/index.php?rid=3127036&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037266%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: TACE and RFA exhibited similar therapeutic effects in terms of recurrence and survival for patients with a single HCC smaller than 4 cm, if they could exhibited complete responses.
    PMID: 20037266 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127036</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127036</guid>        </item>
        <item>
            <title>Transcriptional profiling and Wnt signaling activation in proliferation of human hepatic stellate cells induced by PDGF-BB.</title>
            <link>http://www.medworm.com/index.php?rid=3127035&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037267%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The up-regulated expression of FZD10 and CAMK2A suggests that the Wnt/Ca(2+) signaling pathway is active in hTERT HSCs and may participate in HSC activation and proliferation.
    PMID: 20037267 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127035</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127035</guid>        </item>
        <item>
            <title>[A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C.]</title>
            <link>http://www.medworm.com/index.php?rid=3127034&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037268%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The 24-week plus additional split 24-week therapy following failure is a useful treatment strategy for patients with genotype 1 CHC.
    PMID: 20037268 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127034</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127034</guid>        </item>
        <item>
            <title>[Two cases of toxic hepatitis caused by arrowroot juice.]</title>
            <link>http://www.medworm.com/index.php?rid=3127033&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037269%26dopt%3DAbstract</link>
            <description>We describe two cases of symptomatic toxic hepatitis that developed in middle-aged women after ingesting arrowroot juice. The clinical manifestations were nausea, vomiting, and jaundice. The diagnosis of toxic hepatitis was made using the Roussel Uclaf Causality Assessment Method score on the basis of the patient's history and laboratory data. After supportive care, the patients showed rapid improvements of clinical symptoms, laboratory findings, and liver stiffness. Clinicians should be aware that the consumption of arrowroot juice can cause toxic hepatitis.
    PMID: 20037269 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127033</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127033</guid>        </item>
        <item>
            <title>[A case of primary hepatic epithelioid hemangioendothelioma with spontaneous rupture.]</title>
            <link>http://www.medworm.com/index.php?rid=3127032&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037270%26dopt%3DAbstract</link>
            <description>We present a case of primary hepatic epithelioid hemangioendothelioma in a 65-year-old male patient with alcoholic liver cirrhosis. He was hospitalized due to epigastric pain and multiple liver masses on abdominal ultrasound. Dynamic liver CT imaging revealed multiple peripheral nodular enhanced mass lesions with delayed centripetal enhancement, and the adjacent collection of high-attenuation fluid along the liver capsule. Abdominal tapping revealed blood in the peritoneal cavity. Primary hepatic epithelioid hemangioendothelioma with spontaneous rupture was finally diagnosed based on a histopathologic examination revealing positive immunohistochemical staining for CD34.
    PMID: 20037270 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127032</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127032</guid>        </item>
        <item>
            <title>[A case of acute cholestatic hepatitis induced by Corydalis speciosa Max.]</title>
            <link>http://www.medworm.com/index.php?rid=3127031&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037271%26dopt%3DAbstract</link>
            <description>We report herein a case of hepatotoxicity induced by Corydalis speciosa Max. A 37-year-old male complained of jaundice and mild abdominal discomfort. A thorough history was taken, and laboratory investigation, diagnostic imaging studies, and percutaneous liver biopsy sampling were conducted to determine the cause of liver injury. An accurate cause was not revealed. We administered supportive management for acute cholestatic hepatitis of unknown origin, after which his symptoms disappeared and serum aminotransferase levels decreased gradually to near normal levels. However, at 2 months after discharge, the symptoms and the elevation of aminotransferase levels recurred. At that time he told us that he had repeatedly but unintentionally eaten a herb called &quot;Hwang-geun cho&quot;(Corydalis speciosa ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127031</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127031</guid>        </item>
        <item>
            <title>[Intrahepatic cholangiocarcinoma associated with Clonorchis sinensis infection.]</title>
            <link>http://www.medworm.com/index.php?rid=3127030&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037272%26dopt%3DAbstract</link>
            <description>Authors: Jeen YM, Jin SY
    
    PMID: 20037272 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127030</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127030</guid>        </item>
        <item>
            <title>[Neuroendocrine tumors of the liver.]</title>
            <link>http://www.medworm.com/index.php?rid=3127029&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037273%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 20037273 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127029</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127029</guid>        </item>
        <item>
            <title>[Role of cadherin-17 in hepatocellular carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=3127028&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D20037274%26dopt%3DAbstract</link>
            <description>Authors: Hahn T
    
    PMID: 20037274 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3127028</comments>
            <pubDate>Tue, 01 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3127028</guid>        </item>
        <item>
            <title>[Haplotype analysis at R778L mutation of ATP7B gene in Korean patients with Wilson disease.]</title>
            <link>http://www.medworm.com/index.php?rid=2843181&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783878%26dopt%3DAbstract</link>
            <description>Authors: Jin HS, Oh B
    
    PMID: 19783878 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843181</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843181</guid>        </item>
        <item>
            <title>Molecular targeting for treatment of advanced hepatocellular carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=2843180&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783879%26dopt%3DAbstract</link>
            <description>Authors: Song IH
    Hepatocellular carcinoma (HCC) is a major global health problem, which has a grave morbidity and mortality. Over the past few decades, no effective systemic therapeutic modalities have been established for patients with the unresectable HCC in advanced stage. Sorafenib is a small molecule that blocks cancer cell proliferation by targeting the intracellular signaling pathway at the level of Raf-1 and B-Raf serine-threonine kinases, and exerts an anti-angiogenic effect by targeting the vascular endothelial growth factor receptor-1, 2 and 3, and platelet-derived growth factor receptor-beta tyrosine kinases. Recently, two clinical successful applications, SHARP and Asia-Pacific trial, of multikinase inhibitor sorafenib represent a significant advance in the treatment of ad...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843180</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843180</guid>        </item>
        <item>
            <title>[Haplotype analysis and possible founder effect at the R778L mutation of the ATP7B gene in Korean patients with Wilson's disease.]</title>
            <link>http://www.medworm.com/index.php?rid=2843179&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783880%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The arche haplotype of the ATP7B gene in Korean patients with WD may be 5-R778L-4 (D13S315.mutation.D13S316), and it might illustrate a founder effect.
    PMID: 19783880 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843179</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843179</guid>        </item>
        <item>
            <title>Prognostic value of serum osteopontin in hepatocellular carcinoma patients treated with transarterial chemoembolization.</title>
            <link>http://www.medworm.com/index.php?rid=2843178&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783881%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Serum OPN levels were significantly higher in patients with advanced HCC. In addition, HCC patients with low pretreatment serum OPN levels and those for whom serum OPN declined following TACE exhibited better tumor responses and survived for longer.
    PMID: 19783881 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843178</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843178</guid>        </item>
        <item>
            <title>[Efficacy of 48-week clevudine therapy for chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=2843177&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783882%26dopt%3DAbstract</link>
            <description>CONCLUSION: A 48-week course of clevudine therapy was highly effective in patients with CHB. The risk of development of resistance to clevudine was increased in patients with previous exposure to lamivudine and cirrhosis.
    PMID: 19783882 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843177</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843177</guid>        </item>
        <item>
            <title>Impact of adherence to peginterferon-ribavirin combination therapy in chronic hepatitis C patients on achieving a sustained virologic response.</title>
            <link>http://www.medworm.com/index.php?rid=2843176&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783883%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Adherence to therapy is a key factor in achieving an SVR. Supportive strategies to improve adherence will increase overall SVR rates.
    PMID: 19783883 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843176</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843176</guid>        </item>
        <item>
            <title>[Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=2843175&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783884%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Both MELD and HVPG are independent prognostic factors of death within 3 and 12 months in patients with decompensated liver cirrhosis, and their accuracies are similar. However, HVPG has a limited role in the prediction of death in decompensated cirrhosis due to its invasiveness and limited use.
    PMID: 19783884 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843175</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843175</guid>        </item>
        <item>
            <title>[A case of metastatic hepatocellular carcinoma of the rib, treated by transcatheter arterial chemoembolization.]</title>
            <link>http://www.medworm.com/index.php?rid=2843174&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783885%26dopt%3DAbstract</link>
            <description>We report a rare case of rib metastasis from HCC treated by transcatheter arterial chemoembolization (TACE). A 55-year-old man with liver cirrhosis presented with right lower chest pain. The diagnosis was an HCC with a bone metastasis in the right eighth rib. Intra-arterial injections of doxorubicin mixed with Lipiodol and Gelfoam particles were instituted through the right eighth intercostal artery. Computed tomography and a Tc(99)-labeled scan performed 2 months after the third TACE revealed no viable HCC in the right eighth rib.
    PMID: 19783885 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843174</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843174</guid>        </item>
        <item>
            <title>[Four patients with hepatitis A presenting with fulminant hepatitis and acute renal failure and who underwent liver transplantation.]</title>
            <link>http://www.medworm.com/index.php?rid=2843173&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783886%26dopt%3DAbstract</link>
            <description>We report four cases of hepatitis A in which patients presented with fulminant hepatitis and acute renal failure and underwent liver transplantation. The following common features were observed in our cases: (1) occurrence in relatively old age (&amp;gt;/=39 years old), (2) association with acute renal failure, (3) presence of hepatomegaly, and (4) microscopic features of submassive hepatic necrosis.
    PMID: 19783886 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843173</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843173</guid>        </item>
        <item>
            <title>[A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C.]</title>
            <link>http://www.medworm.com/index.php?rid=2843172&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783887%26dopt%3DAbstract</link>
            <description>We report a 60-year-old male patient who developed sudden-onset hearing loss during combination therapy with pegylated interferon alpha and ribavirin for chronic hepatitis C. This patient had been diagnosed with chronic hepatitis C (genotype Ib) and early-stage liver cirrhosis 3 years previously, and had been treated with conventional interferon-alpha and ribavirin for 12 months. However, 6 months from the end of the treatment course the patient relapsed and received combination retreatment with pegylated interferon alpha-2b and ribavirin. He developed sudden-onset right-side hearing loss and tinnitus 42 weeks after the start of this retreatment. Pure-tone audiometry revealed a right-side hearing loss of 60~90dB. The patient consequently immediately discontinued the pegylated interferon th...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843172</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843172</guid>        </item>
        <item>
            <title>[Large liver cell change/dysplasia in hepatitis B virus-related liver cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=2843171&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783888%26dopt%3DAbstract</link>
            <description>Authors: Kim H, Park YN
    
    PMID: 19783888 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843171</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843171</guid>        </item>
        <item>
            <title>[Peliosis hepatis.]</title>
            <link>http://www.medworm.com/index.php?rid=2843170&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783889%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 19783889 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843170</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843170</guid>        </item>
        <item>
            <title>[Clinical outcomes and development of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients.]</title>
            <link>http://www.medworm.com/index.php?rid=2843169&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783890%26dopt%3DAbstract</link>
            <description>Authors: Kim JH
    
    PMID: 19783890 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843169</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843169</guid>        </item>
        <item>
            <title>[Practice guidelines for management of hepatocellular carcinoma 2009.]</title>
            <link>http://www.medworm.com/index.php?rid=2843168&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783891%26dopt%3DAbstract</link>
            <description>Authors:  
    Hepatocellular carcinoma (HCC) is a major cancer in Korea, typically has a poor prognosis, and constitutes the majority of primary hepatic malignancies. It is the number one cause of death among people in their 50s in Korea. The five-year survival rate of liver cancer is poor; at 18.9%. Efforts to increase the survival rate through early diagnosis of HCC and optimal treatments are keenly needed. Western guideline for the management of HCC were developed, but these guidelines are somewhat unsuitable for Korean patients. Thus, the Korean Liver Cancer Study Group (KLCSG) and the National Cancer Center (NCC), Korea jointly produced the Clinical Practice Guidelines for HCC for the first time in Korea in 2003. Owing to medical advances over the following six years, diagnosis and t...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843168</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843168</guid>        </item>
        <item>
            <title>[Corrections: Distribution of hepatitis B virus genotypes in Korea.]</title>
            <link>http://www.medworm.com/index.php?rid=2843167&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19783892%26dopt%3DAbstract</link>
            <description>Authors: Cho JH, Yoon KH, Lee KE, Park do S, Lee YJ, Moon HB, Lee KR, Choi CS, Cho EY, Kim HC
    
    PMID: 19783892 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2843167</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2843167</guid>        </item>
        <item>
            <title>[Clevudine therapy in patients with chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=2581438&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581763%26dopt%3DAbstract</link>
            <description>Authors: Lee KS
    
    PMID: 19581763 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581438</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581438</guid>        </item>
        <item>
            <title>[Pathology of nonalcoholic steatohepatitis.]</title>
            <link>http://www.medworm.com/index.php?rid=2581437&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581764%26dopt%3DAbstract</link>
            <description>Authors: Jeen YM, Jin SY
    Nonalcoholic steatohepatitis (NASH), one of the NAFLDs (nonalcoholic fatty liver diseases), is regarded as a hepatic manifestation of metabolic syndrome. NASH can progress to cirrhosis, and possibly to hepatic malignancy. Currently, liver biopsy is the only reliable method of assessing the presence or absence of NASH and the stage of fibrosis. The finding of steatosis with evidence of hepatocyte injury such as inflammation, ballooning, degeneration, and/or fibrosis, is generally essential for making a diagnosis of NASH. However, its diagnostic criteria have not yet been established. The pathologic findings of NASH and related diseases, and the grading system currently in use are reviewed herein.
    PMID: 19581764 [PubMed - in process] (Source: Korean J Hepatol...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581437</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581437</guid>        </item>
        <item>
            <title>[Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation.]</title>
            <link>http://www.medworm.com/index.php?rid=2581436&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581765%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Due to the adoptive immunity that was transferred from anti-HBs-positive donors, a seroconversion of HBsAg could occur in some HBsAg-positive recipients. HBsAg-positive donors had a lesser effect on the HBV serologic markers of recipients. However, a reactivation of HBV can occur following hematopoietic stem-cell transplantation in the cases of recipients or donors with a history of HBV, infection by an accompanying immune suppression. Therefore, prevention should be instigated.
    PMID: 19581765 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581436</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581436</guid>        </item>
        <item>
            <title>[Distribution of hepatitis B virus genotypes in Korea.]</title>
            <link>http://www.medworm.com/index.php?rid=2581435&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581766%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The prevailing HBV genotype in Korea is C2; the other genotypes occur only rarely. Future studies should include confirmation of the detection of genotypes other than C.
    PMID: 19581766 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581435</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581435</guid>        </item>
        <item>
            <title>[Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=2581434&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581767%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The prognosis in patients with ruptured HCCs was poor with a 30-day mortality of 43.5%. The early deaths after the rupture of HCC were associated with elevated serum bilirubin levels, hepatic encephalopathy, and the massive or diffuse type of tumor morphology.
    PMID: 19581767 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581434</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581434</guid>        </item>
        <item>
            <title>[Clinical features of hepatic tuberculosis in biopsy-proven cases.]</title>
            <link>http://www.medworm.com/index.php?rid=2581433&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581768%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In patients with a protracted illness, hepatosplenomegaly and/or abnormal liver function tests, hepatic tuberculosis should be suspected, even in healthy young patients or patients with normal imaging findings. Patients with tuberculous abscess formation tend to respond poorly to antituberculosis therapy, and surgery could be considered in these patients.
    PMID: 19581768 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581433</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581433</guid>        </item>
        <item>
            <title>[Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=2581432&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581769%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Younger children (age &amp;lt;7 years old) have a higher chance of HBsAg clearance than older children after the treatment of HBeAg-positive chronic hepatitis B with lamivudine.
    PMID: 19581769 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581432</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581432</guid>        </item>
        <item>
            <title>[Long-term clevudine therapy in nucleos(t)ide-naïve and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases.]</title>
            <link>http://www.medworm.com/index.php?rid=2581431&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581770%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Clevudine is one of the recommended first-line medicines for the treatment of chronic hepatitis B, but it is not free from resistance, particularly in patients with a history of previous lamivudine treatment, but also in naive patients. Clevudine should be avoided in previously lamivudine-exposed patients. In addition, reelevation of serum AST and CPK levels is not a rare occurrence, and close observation and follow-up tests are essential.
    PMID: 19581770 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581431</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581431</guid>        </item>
        <item>
            <title>[A case of hypervascular hyperplastic nodules mimicking hepatocellular carcinoma in alcoholic liver cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=2581430&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581771%26dopt%3DAbstract</link>
            <description>We report herein a case of benign HHN mimicking hepatocellular carcinoma in a 32-year-old male alcoholic liver cirrhosis patient without viral hepatitis infection.
    PMID: 19581771 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581430</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581430</guid>        </item>
        <item>
            <title>[A case of liver metastasis of gastric hepatoid adenocarcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=2581429&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581772%26dopt%3DAbstract</link>
            <description>We report herein a case of hepatoid adenocarcinoma of the stomach with liver metastasis. Gastric carcinoma generally presents as adenocarcinoma and rarely shows a hepatoid pattern, which can produce alpha-fetoprotein (AFP). The stomach is one of the common sites at which hepatoid adenocarcinoma has been detected. A 75-year-old female patient was admitted to the hospital with a symptom of epigastric discomfort. Gastrofibroscopy revealed a large tumor occupying the greater curvature of the stomach body. The level of serum AFP was markedly increased. Abdominal computed tomography revealed multiple liver masses. Biopsy samples of the gastric lesion and liver masses finally confirmed her case as hepatoid adenocarcinoma in the stomach with liver metastasis. The AFP-producing gastric carcinoma ne...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581429</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581429</guid>        </item>
        <item>
            <title>Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.</title>
            <link>http://www.medworm.com/index.php?rid=2581428&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581773%26dopt%3DAbstract</link>
            <description>Authors: Kang HM, Park MJ, Hwang JM, Kim JW, Jeong SH
    A 63-year-old male experienced sudden diplopia after 9 weeks of administration of pegylated interferon (IFN) alpha-2b and ribavirin for chronic hepatitis C (CHC). Ophthalmologic examinations showed ptosis on the right upper lid and restricted right eye movement without any other neurological signs. A brain imaging study and repetitive nerve stimulation test indicated no abnormality. The acetylcholine receptor antibody titer and response to acetylcholinesterase inhibitors were negative, and the results of thyroid function tests were normal. The patient's ophthalmological symptoms improved rapidly 3 weeks after discontinuation of pegylated IFN alpha-2b and ribavirin. The ocular myasthenia associated with combination therapy of pegylat...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581428</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581428</guid>        </item>
        <item>
            <title>[Primary angiosarcoma of the liver.]</title>
            <link>http://www.medworm.com/index.php?rid=2581427&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581774%26dopt%3DAbstract</link>
            <description>Authors: Seok JY, Kim YB
    
    PMID: 19581774 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581427</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581427</guid>        </item>
        <item>
            <title>[Epithelioid hemangioendothelioma.]</title>
            <link>http://www.medworm.com/index.php?rid=2581426&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581775%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 19581775 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581426</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581426</guid>        </item>
        <item>
            <title>Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=2581425&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19581776%26dopt%3DAbstract</link>
            <description>Authors: Heo J
    
    PMID: 19581776 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2581425</comments>
            <pubDate>Sun, 31 May 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2581425</guid>        </item>
        <item>
            <title>[Inhibition of hepatitis B virus replication by RNA interference.]</title>
            <link>http://www.medworm.com/index.php?rid=2309369&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346780%26dopt%3DAbstract</link>
            <description>Authors: Park YG
    
    PMID: 19346780 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309369</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309369</guid>        </item>
        <item>
            <title>[Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection.]</title>
            <link>http://www.medworm.com/index.php?rid=2309367&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346781%26dopt%3DAbstract</link>
            <description>Authors: Kim YJ, Lee HS
    Hepatocellular carcinoma (HCC) is associated with hepatitis B virus (HBV) as an etiologic agent in 80% of cases, and is the major cause of death among HBV carriers. Family history of HCC is a known risk factor for the development of HCC among chronically HBV infected patients; therefore, genetic factors are likely to modify the risk of HCC. However, the genetic factors that determine progression to HCC remain mostly to be recovered. It is estimated that there are millions of single nucleotide polymorphisms (SNPs) within human genome and they are likely to explain much of the genetic diversity of individuals. In this review, the natural history of HBV infection and host genetic factors related to HCC, study design and target gene selection for the detection of SN...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309367</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309367</guid>        </item>
        <item>
            <title>[Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx.]</title>
            <link>http://www.medworm.com/index.php?rid=2309365&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346782%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Lentivirus-mediated delivery of shRNA against HBx can effectively suppress the replication of HBV and reduce HBV cccDNA in cell culture systems.
    PMID: 19346782 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309365</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309365</guid>        </item>
        <item>
            <title>[Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea.]</title>
            <link>http://www.medworm.com/index.php?rid=2309363&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346783%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Antiviral treatment of CHB with LMV or ADV for up to 5 years using the alternative antiviral agent as rescue medication appears to be a cost-effective strategy for both HBeAg-positive and HBeAg-negative CHB patients in Korea. Economic evaluation of antiviral therapies should be studied further and updated, particularly for newer agents.
    PMID: 19346783 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309363</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309363</guid>        </item>
        <item>
            <title>[The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease.]</title>
            <link>http://www.medworm.com/index.php?rid=2309360&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346784%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Transient elastography is a useful method for diagnosing cirrhosis in patients with alcoholic liver disease.
    PMID: 19346784 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309360</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309360</guid>        </item>
        <item>
            <title>[Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients.]</title>
            <link>http://www.medworm.com/index.php?rid=2309358&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346785%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Our data suggest that the adefovir-monotherapy-induced virologic response is not durable in most patients with LAMV-R HBeAg-positive CHB, especially in those with a high pretreatment HBV DNA level.
    PMID: 19346785 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309358</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309358</guid>        </item>
        <item>
            <title>[The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease.]</title>
            <link>http://www.medworm.com/index.php?rid=2309356&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346786%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The results of our study suggest that RBP4 is a serologic marker for disease severity in patients with CLD. It could also be useful as an early marker of CLD and of the relative success of antiviral therapy.
    PMID: 19346786 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309356</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309356</guid>        </item>
        <item>
            <title>[Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C.]</title>
            <link>http://www.medworm.com/index.php?rid=2309354&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346787%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Reappearance of HCV RNA after earlier achievement of an SVR might appear more frequently than previously reported. Close follow-up of these patients is recommended and the implication of temporary viremia should be determined in the future.
    PMID: 19346787 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309354</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309354</guid>        </item>
        <item>
            <title>[A case of hepatocellular carcinoma invading the gallbladder misdiagnosed as a primary gallbladder carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=2309352&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346788%26dopt%3DAbstract</link>
            <description>We report here a case of HCC that directly invaded the gallbladder, and that resembled gallbladder carcinoma invading the liver.
    PMID: 19346788 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309352</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309352</guid>        </item>
        <item>
            <title>[A case of rhabdomyolysis during hospitalization for acute hepatitis A.]</title>
            <link>http://www.medworm.com/index.php?rid=2309350&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346789%26dopt%3DAbstract</link>
            <description>We report a case of acute hepatitis A complicated by rhabdomyolysis during hospitalization.
    PMID: 19346789 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309350</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309350</guid>        </item>
        <item>
            <title>[A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy.]</title>
            <link>http://www.medworm.com/index.php?rid=2309348&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346790%26dopt%3DAbstract</link>
            <description>We report here a case of advanced HCC with portal vein tumor thrombosis that was effectively treated with percutaneous ethanol injection (PEI), having previously enabled subsequent successive transarterial chemoembolization (TACE). A 60-year-old male patient was diagnosed with a huge HCC, based on computed tomography and angiographic findings. Despite two sessions of TACE, the tumor invaded the right portal vein. PEI was performed on the malignant portal vein thrombosis, and three sessions thereof reduced the extent of tumor thrombi in the portal vein. Successive TACEs were performed to treat the HCC in the hepatic parenchyma. The patient was still living 19 months after the first PEI with no evidence of tumor recurrence, and his liver function remained well preserved.
    PMID: 19346790 [...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309348</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309348</guid>        </item>
        <item>
            <title>[Well differentiated hepatocellular carcinoma: ddmPathological diagnosis of needle biopsied liver tissue.]</title>
            <link>http://www.medworm.com/index.php?rid=2309346&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346791%26dopt%3DAbstract</link>
            <description>Authors: Seok JY, Park YN
    
    PMID: 19346791 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309346</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309346</guid>        </item>
        <item>
            <title>[Angiosarcoma.]</title>
            <link>http://www.medworm.com/index.php?rid=2309344&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346792%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 19346792 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309344</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309344</guid>        </item>
        <item>
            <title>Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.</title>
            <link>http://www.medworm.com/index.php?rid=2309342&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19346793%26dopt%3DAbstract</link>
            <description>Authors: Park NH
    
    PMID: 19346793 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309342</comments>
            <pubDate>Sun, 01 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309342</guid>        </item>
        <item>
            <title>[Treatment of chronic hepatitis C: efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients]</title>
            <link>http://www.medworm.com/index.php?rid=2309393&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119239%26dopt%3DAbstract</link>
            <description>Authors: Lee YJ
    
    PMID: 19119239 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309393</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309393</guid>        </item>
        <item>
            <title>[Hepatitis B virus genetic diversity and mutant]</title>
            <link>http://www.medworm.com/index.php?rid=2309391&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119240%26dopt%3DAbstract</link>
            <description>Authors: Yim HJ
    Hepatitis B virus (HBV) is a partially double stranded DNA virus with genetic diversity represented by eight genotypes (A to H). Natural course and response to treatment could be affected by HBV genotypes. HBV shows high rates of turn over in the absence of proof-reading ability. As a result, large amounts of quasispecies are produced naturally or antiviral-associated. HBV consists of four open reading frames, namely preS/S gene, precore/core gene, polymerase gene, and X gene. Mutations on preS gene can result in undetectable HBsAg even in case that HBV is replicating. Surface gene mutation leads to decreased binding affinity to anti-HBs, which is associated with a vaccine escape mutant. Precore mutation abolishes HBeAg whereas mutations on basal core promoter gene down...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309391</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309391</guid>        </item>
        <item>
            <title>[Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A]</title>
            <link>http://www.medworm.com/index.php?rid=2309388&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119242%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: FHF due to hepatitis A has increased in recent years, and in our cohort the HEP grade was closely associated with spontaneous survival.
    PMID: 19119242 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309388</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309388</guid>        </item>
        <item>
            <title>[Clinical characteristics of 159 cases of acute toxic hepatitis]</title>
            <link>http://www.medworm.com/index.php?rid=2309386&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119243%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The main cause of acute toxic hepatitis in the current study was the use of herbal medicines. The severity of liver injury at the time of admission was a major factor significantly associated with the hospitalization and recovery periods.
    PMID: 19119243 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309386</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309386</guid>        </item>
        <item>
            <title>[Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: a comparative study]</title>
            <link>http://www.medworm.com/index.php?rid=2309383&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119244%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: We found no significant differences in therapeutic efficacies and adverse effects between the alpha-2a and -2b types of peginterferon as the initial treatment regimen in naive chronic hepatitis C patients.
    PMID: 19119244 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309383</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309383</guid>        </item>
        <item>
            <title>[The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection]</title>
            <link>http://www.medworm.com/index.php?rid=2309381&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119245%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Although ADV monotherapy is effective, it leads to a high rate of mutations of HBV DNA reverse transcriptase gene in patients with chronic HBV infections who have LMV-resistant HBV mutants.
    PMID: 19119245 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309381</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309381</guid>        </item>
        <item>
            <title>[A case report of treatment with pegylated interferon alpha for lamivudine-resistant chronic hepatitis B virus infection]</title>
            <link>http://www.medworm.com/index.php?rid=2309379&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119246%26dopt%3DAbstract</link>
            <description>Authors: Hur WH, Woo HY, Jeong SW, You CR, Bae SH, Choi JY, Yoon SK
    The wide use of lamivudine in chronic hepatitis B has produced a monotonic increase in patients with lamivudine resistance. Therefore, treating lamivudine resistance in chronic hepatitis B is a major concern in clinical practice for the treatment of hepatitis B virus (HBV). There is conflicting evidence on the outcome of pegylated interferon alpha (PEG-IFN alpha) therapy against lamivudine-resistant HBV, which is due to mutations in the YMDD motif. We experienced a patient with chronic hepatitis B who was successfully treated with PEG-IFN alpha-2a after the development of virologic and biochemical breakthrough during lamivudine therapy. Virologic breakthrough was associated with the emergence of YMDD mutants 48 months ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309379</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309379</guid>        </item>
        <item>
            <title>[Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation]</title>
            <link>http://www.medworm.com/index.php?rid=2309377&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119247%26dopt%3DAbstract</link>
            <description>We report the clinical course and antiviral response in a patient with FCH due to recurrent hepatitis C after cadaveric liver transplantation who was treated with pegylated interferon alpha-2a and ribavirin.
    PMID: 19119247 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309377</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309377</guid>        </item>
        <item>
            <title>[A case of hepatic epithelioid hemangioendothelioma that caused extrahepatic metastases without intrahepatic recurrence after hepatic resection]</title>
            <link>http://www.medworm.com/index.php?rid=2309375&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119248%26dopt%3DAbstract</link>
            <description>We report a case of a 64-year old woman who underwent hepatic resection due to epithelioid hemangioendothelioma in the right lobe that progressed to extrahepatic metastases of the bone, pleura, and peritoneum 22 months later. However, after resection there was no primary hepatic recurrence.
    PMID: 19119248 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309375</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309375</guid>        </item>
        <item>
            <title>[Mucin hypersecreting cholangiocarcinoma]</title>
            <link>http://www.medworm.com/index.php?rid=2309373&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119249%26dopt%3DAbstract</link>
            <description>Authors: Jeen YM, Jin SY
    
    PMID: 19119249 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309373</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309373</guid>        </item>
        <item>
            <title>[Focal nodular hyperplasia-like nodule]</title>
            <link>http://www.medworm.com/index.php?rid=2309371&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119250%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 19119250 [PubMed - indexed for MEDLINE] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2309371</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2309371</guid>        </item>
        <item>
            <title>[Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients.]</title>
            <link>http://www.medworm.com/index.php?rid=2077424&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119239%26dopt%3DAbstract</link>
            <description>Authors: Lee YJ
    
    PMID: 19119239 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077424</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077424</guid>        </item>
        <item>
            <title>[Hepatitis B virus genetic diversity and mutant.]</title>
            <link>http://www.medworm.com/index.php?rid=2077423&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119240%26dopt%3DAbstract</link>
            <description>Authors: Yim HJ
    Hepatitis B virus (HBV) is a partially double stranded DNA virus with genetic diversity represented by eight genotypes (A to H). Natural course and response to treatment could be affected by HBV genotypes. HBV shows high rates of turn over in the absence of proof-reading ability. As a result, large amounts of quasispecies are produced naturally or antiviral-associated. HBV consists of four open reading frames, namely preS/S gene, precore/core gene, polymerase gene, and X gene. Mutations on preS gene can result in undetectable HBsAg even in case that HBV is replicating. Surface gene mutation leads to decreased binding affinity to anti-HBs, which is associated with a vaccine escape mutant. Precore mutation abolishes HBeAg whereas mutations on basal core promoter gene down...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077423</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077423</guid>        </item>
        <item>
            <title>Changes in liver stiffness during the course of acute hepatitis A.</title>
            <link>http://www.medworm.com/index.php?rid=2077422&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119241%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Severe hepatic inflammation can affect the LS findings and thus, care is required when assessing fibrosis stage using LS measurement in patients with severe inflammation.
    PMID: 19119241 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077422</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077422</guid>        </item>
        <item>
            <title>[Clinical outcomes and predictive factors of spontaneous survival in patients with fulminant hepatitis A.]</title>
            <link>http://www.medworm.com/index.php?rid=2077421&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119242%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: FHF due to hepatitis A has increased in recent years, and in our cohort the HEP grade was closely associated with spontaneous survival.
    PMID: 19119242 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077421</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077421</guid>        </item>
        <item>
            <title>[Clinical characteristics of 159 cases of acute toxic hepatitis.]</title>
            <link>http://www.medworm.com/index.php?rid=2077420&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119243%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The main cause of acute toxic hepatitis in the current study was the use of herbal medicines. The severity of liver injury at the time of admission was a major factor significantly associated with the hospitalization and recovery periods.
    PMID: 19119243 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077420</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077420</guid>        </item>
        <item>
            <title>[Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: A comparative study.]</title>
            <link>http://www.medworm.com/index.php?rid=2077419&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119244%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: We found no significant differences in therapeutic efficacies and adverse effects between the alpha-2a and -2b types of peginterferon as the initial treatment regimen in naive chronic hepatitis C patients.
    PMID: 19119244 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077419</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077419</guid>        </item>
        <item>
            <title>[The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with lamivudine-resistant chronic hepatitis B infection.]</title>
            <link>http://www.medworm.com/index.php?rid=2077418&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119245%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Although ADV monotherapy is effective, it leads to a high rate of mutations of HBV DNA reverse transcriptase gene in patients with chronic HBV infections who have LMV-resistant HBV mutants.
    PMID: 19119245 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077418</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077418</guid>        </item>
        <item>
            <title>[A case report of treatment with pegylated interferon alpha for lamivudine-resistant chronic hepatitis B virus infection.]</title>
            <link>http://www.medworm.com/index.php?rid=2077417&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119246%26dopt%3DAbstract</link>
            <description>Authors: Hur WH, Woo HY, Jeong SW, You CR, Bae SH, Choi JY, Yoon SK
    The wide use of lamivudine in chronic hepatitis B has produced a monotonic increase in patients with lamivudine resistance. Therefore, treating lamivudine resistance in chronic hepatitis B is a major concern in clinical practice for the treatment of hepatitis B virus (HBV). There is conflicting evidence on the outcome of pegylated interferon alpha (PEG-IFN alpha) therapy against lamivudine-resistant HBV, which is due to mutations in the YMDD motif. We experienced a patient with chronic hepatitis B who was successfully treated with PEG-IFN alpha-2a after the development of virologic and biochemical breakthrough during lamivudine therapy. Virologic breakthrough was associated with the emergence of YMDD mutants 48 months ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077417</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077417</guid>        </item>
        <item>
            <title>[Treatment with pegylated interferon and ribavirin in a patient with fibrosing cholestatic hepatitis due to recurrent hepatitis C after liver transplantation.]</title>
            <link>http://www.medworm.com/index.php?rid=2077416&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119247%26dopt%3DAbstract</link>
            <description>We report the clinical course and antiviral response in a patient with FCH due to recurrent hepatitis C after cadaveric liver transplantation who was treated with pegylated interferon alpha-2a and ribavirin.
    PMID: 19119247 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077416</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077416</guid>        </item>
        <item>
            <title>[A case of hepatic epithelioid hemangioendothelioma that caused extrahepatic metastases without intrahepatic recurrence after hepatic resection.]</title>
            <link>http://www.medworm.com/index.php?rid=2077415&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119248%26dopt%3DAbstract</link>
            <description>We report a case of a 64-year old woman who underwent hepatic resection due to epithelioid hemangioendothelioma in the right lobe that progressed to extrahepatic metastases of the bone, pleura, and peritoneum 22 months later. However, after resection there was no primary hepatic recurrence.
    PMID: 19119248 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077415</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077415</guid>        </item>
        <item>
            <title>[Mucin hypersecreting cholangiocarcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=2077414&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119249%26dopt%3DAbstract</link>
            <description>Authors: Jeen YM, Jin SY
    
    PMID: 19119249 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077414</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077414</guid>        </item>
        <item>
            <title>[Focal nodular hyperplasia-like nodule.]</title>
            <link>http://www.medworm.com/index.php?rid=2077413&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119250%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 19119250 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077413</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077413</guid>        </item>
        <item>
            <title>[Risk factors for mortality after surgery in patients with cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=2077412&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D19119251%26dopt%3DAbstract</link>
            <description>Authors: Lee JH
    
    PMID: 19119251 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2077412</comments>
            <pubDate>Mon, 01 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2077412</guid>        </item>
        <item>
            <title>[Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor]</title>
            <link>http://www.medworm.com/index.php?rid=1857946&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815453%26dopt%3DAbstract</link>
            <description>Authors: Jang JW
    
    PMID: 18815453 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857946</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857946</guid>        </item>
        <item>
            <title>[Clinical application of stem cells in liver diseases]</title>
            <link>http://www.medworm.com/index.php?rid=1857945&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815454%26dopt%3DAbstract</link>
            <description>Authors: Bae SH
    Most liver diseases lead to hepatic dysfunction with organ failure. Liver transplantation is the best curative therapy, but it has some limitations such as donor shortage, possibility of rejection, and maintenance of immunosuppressant. New therapies have been actively searched for over several decades, primarily in the form of artificial liver support devices and hepatocyte transplantation, but both of these modalities remain experimental. Stem cells have recently shown promise in cell therapy because they have the capacity for self-renewal and multilineage differentiation, and are applicable to human diseases. Very recent reports of unexpected plasticity in adult bone marrow have raised hopes of stem cell therapy offering exciting therapeutic possibilities for patients...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857945</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857945</guid>        </item>
        <item>
            <title>[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection]</title>
            <link>http://www.medworm.com/index.php?rid=1857944&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815455%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In Korean patients with chronic hepatitis C, a regimen of peginterferon and ribavirin was more effective than a regimen of conventional interferon and ribavirin. This result is comparable to those from studies on Western patients as an initial treatment for chronic hepatitis C.
    PMID: 18815455 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857944</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857944</guid>        </item>
        <item>
            <title>[Natural history of gastric varices and risk factors for bleeding]</title>
            <link>http://www.medworm.com/index.php?rid=1857943&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815456%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: GV bleeding was more frequent in patients with fundal varices than in patients with type 1 gastroesophageal varices, and large GV and poor liver function were risk factors for GV bleeding. Close observation and prophylaxis for variceal bleeding might be warranted in high-risk patients.
    PMID: 18815456 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857943</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857943</guid>        </item>
        <item>
            <title>[Usefulness of liver stiffness measurement for predicting the presence of esophageal varices in patients with liver cirrhosis]</title>
            <link>http://www.medworm.com/index.php?rid=1857942&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815457%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: LSM is useful for predicting the presence of EV in patients with cirrhosis but not their size.
    PMID: 18815457 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857942</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857942</guid>        </item>
        <item>
            <title>[Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor]</title>
            <link>http://www.medworm.com/index.php?rid=1857941&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815458%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Survivin was down-regulated in the growth inhibition of hepatoma cells induced by a selective COX-2 inhibitor, NS-398, in a concentration- and time-dependent manner. These results suggest the therapeutic inhibition of COX-2 via suppression of survivin in HCC.
    PMID: 18815458 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857941</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857941</guid>        </item>
        <item>
            <title>[Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases]</title>
            <link>http://www.medworm.com/index.php?rid=1857940&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815459%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: We found that systemic chemotherapy was not effective in treating HCC presenting with multiple lung metastases. Improving the effectiveness of systemic treatment and selecting patients who would benefit from such treatment remains a major challenge.
    PMID: 18815459 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857940</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857940</guid>        </item>
        <item>
            <title>[Risk factors for early recurrence after surgical resection for hepatocellular carcinoma]</title>
            <link>http://www.medworm.com/index.php?rid=1857939&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815460%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Preoperative serum AFP and AST levels were the independent risk factors for ER after surgical resection for HCC. Close postoperative surveillance is recommended for early detection of recurrence and additional treatments in patients with these factors.
    PMID: 18815460 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857939</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857939</guid>        </item>
        <item>
            <title>[A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus]</title>
            <link>http://www.medworm.com/index.php?rid=1857938&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815461%26dopt%3DAbstract</link>
            <description>Authors: Lee HJ, Choi JW, Kim TN, Eun JR
    Adefovir dipivoxyl (ADV) effectively suppresses hepatitis B virus (HBV) replication but exhibits nephrotoxicity with severe hypophosphatemia when administered at a high dosage. This is the first report of severe hypophosphatemic osteomalacia induced by ADV at 10 mg/day. A 42-year-old man with HBV-related chronic liver disease presented with generalized bone pain, especially in the left ankle. He had been taking ADV for more than 1.5 years following a clinical breakthrough due to lamivudine-resistant HBV. Aggravating severe hypophosphatemia and elevated serum alkaline phosphatase levels with high bone fraction had been noted after 6 months of ADV therapy. Bone densitometry, simple bone X-rays, and a whole-body bone scan demonstrated osteoporosis ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857938</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857938</guid>        </item>
        <item>
            <title>[Three cases of multiple infarcted regenerative nodules in liver cirrhosis after gastrointestinal hemorrhage]</title>
            <link>http://www.medworm.com/index.php?rid=1857937&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815462%26dopt%3DAbstract</link>
            <description>We report three cases of multiple infarcted regenerative nodules in liver cirrhosis after gastrointestinal hemorrhage.
    PMID: 18815462 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857937</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857937</guid>        </item>
        <item>
            <title>[Hepatocellular carcinoma with lymphoid stroma: report of two cases]</title>
            <link>http://www.medworm.com/index.php?rid=1857936&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815463%26dopt%3DAbstract</link>
            <description>We report two cases of hepatocellular carcinoma with prominent lymphocytic infiltration, which has been described as a subtype of hepatocellular carcinoma with good prognosis. One case showed lymphoid follicles and dense lymphocytic infiltrates within the tumor and its periphery, and the other case showed marked lymphocytic infiltration in the cancerous tissue. Piecemeal necrosis of cancer cells and atypical reactive changes were evident. The two cases were seronegative for hepatitis B surface antigen, antibody to hepatitis C virus, and Epstein-Barr virus DNA. One of the cases showed Clonorchis infestation. The prognostic significance of lymphocytic stroma in hepatocellular carcinoma requires further investigation.
    PMID: 18815463 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857936</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857936</guid>        </item>
        <item>
            <title>[Epithelioid hemangioendothelioma of the liver]</title>
            <link>http://www.medworm.com/index.php?rid=1857935&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815464%26dopt%3DAbstract</link>
            <description>Authors: Kim YB
    
    PMID: 18815464 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857935</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857935</guid>        </item>
        <item>
            <title>[Imaging findings of hepatic adenoma]</title>
            <link>http://www.medworm.com/index.php?rid=1857934&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815465%26dopt%3DAbstract</link>
            <description>Authors: Han JK, Eun HW, Kim SH
    
    PMID: 18815465 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1857934</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1857934</guid>        </item>
        <item>
            <title>[Anti-tumor mechanisms and regulation of survivin by selective cyclooxygenase-2 inhibitor.]</title>
            <link>http://www.medworm.com/index.php?rid=1831534&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815453%26dopt%3DAbstract</link>
            <description>Authors: Jang JW
    
    PMID: 18815453 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831534</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831534</guid>        </item>
        <item>
            <title>[Clinical application of stem cells in liver diseases.]</title>
            <link>http://www.medworm.com/index.php?rid=1831533&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815454%26dopt%3DAbstract</link>
            <description>Authors: Bae SH
    Most liver diseases lead to hepatic dysfunction with organ failure. Liver transplantation is the best curative therapy, but it has some limitations such as donor shortage, possibility of rejection, and maintenance of immunosuppressant. New therapies have been actively searched for over several decades, primarily in the form of artificial liver support devices and hepatocyte transplantation, but both of these modalities remain experimental. Stem cells have recently shown promise in cell therapy because they have the capacity for self-renewal and multilineage differentiation, and are applicable to human diseases. Very recent reports of unexpected plasticity in adult bone marrow have raised hopes of stem cell therapy offering exciting therapeutic possibilities for patients...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831533</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831533</guid>        </item>
        <item>
            <title>[Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection.]</title>
            <link>http://www.medworm.com/index.php?rid=1831532&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815455%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: In Korean patients with chronic hepatitis C, a regimen of peginterferon and ribavirin was more effective than a regimen of conventional interferon and ribavirin. This result is comparable to those from studies on Western patients as an initial treatment for chronic hepatitis C.
    PMID: 18815455 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831532</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831532</guid>        </item>
        <item>
            <title>[Natural history of gastric varices and risk factors for bleeding.]</title>
            <link>http://www.medworm.com/index.php?rid=1831531&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815456%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: GV bleeding was more frequent in patients with fundal varices than in patients with type 1 gastroesophageal varices, and large GV and poor liver function were risk factors for GV bleeding. Close observation and prophylaxis for variceal bleeding might be warranted in high-risk patients.
    PMID: 18815456 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831531</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831531</guid>        </item>
        <item>
            <title>[Usefulness of liver stiffness measurement for predicting the presence of esophageal varices in patients with liver cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=1831530&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815457%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: LSM is useful for predicting the presence of EV in patients with cirrhosis but not their size.
    PMID: 18815457 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831530</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831530</guid>        </item>
        <item>
            <title>[Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor.]</title>
            <link>http://www.medworm.com/index.php?rid=1831529&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815458%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Survivin was down-regulated in the growth inhibition of hepatoma cells induced by a selective COX-2 inhibitor, NS-398, in a concentration- and time-dependent manner. These results suggest the therapeutic inhibition of COX-2 via suppression of survivin in HCC.
    PMID: 18815458 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831529</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831529</guid>        </item>
        <item>
            <title>[Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases.]</title>
            <link>http://www.medworm.com/index.php?rid=1831528&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815459%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: We found that systemic chemotherapy was not effective in treating HCC presenting with multiple lung metastases. Improving the effectiveness of systemic treatment and selecting patients who would benefit from such treatment remains a major challenge.
    PMID: 18815459 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831528</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831528</guid>        </item>
        <item>
            <title>[Risk factors for early recurrence after surgical resection for hepatocellular carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=1831527&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815460%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Preoperative serum AFP and AST levels were the independent risk factors for ER after surgical resection for HCC. Close postoperative surveillance is recommended for early detection of recurrence and additional treatments in patients with these factors.
    PMID: 18815460 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831527</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831527</guid>        </item>
        <item>
            <title>[A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus.]</title>
            <link>http://www.medworm.com/index.php?rid=1831526&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815461%26dopt%3DAbstract</link>
            <description>Authors: Lee HJ, Choi JW, Kim TN, Eun JR
    Adefovir dipivoxyl (ADV) effectively suppresses hepatitis B virus (HBV) replication but exhibits nephrotoxicity with severe hypophosphatemia when administered at a high dosage. This is the first report of severe hypophosphatemic osteomalacia induced by ADV at 10 mg/day. A 42-year-old man with HBV-related chronic liver disease presented with generalized bone pain, especially in the left ankle. He had been taking ADV for more than 1.5 years following a clinical breakthrough due to lamivudine-resistant HBV. Aggravating severe hypophosphatemia and elevated serum alkaline phosphatase levels with high bone fraction had been noted after 6 months of ADV therapy. Bone densitometry, simple bone X-rays, and a whole-body bone scan demonstrated osteoporosis ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831526</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831526</guid>        </item>
        <item>
            <title>[Three cases of multiple infarcted regenerative nodules in liver cirrhosis after gastrointestinal hemorrhage.]</title>
            <link>http://www.medworm.com/index.php?rid=1831525&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815462%26dopt%3DAbstract</link>
            <description>We report three cases of multiple infarcted regenerative nodules in liver cirrhosis after gastrointestinal hemorrhage.
    PMID: 18815462 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831525</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831525</guid>        </item>
        <item>
            <title>[Hepatocellular carcinoma with lymphoid stroma: report of two cases.]</title>
            <link>http://www.medworm.com/index.php?rid=1831524&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815463%26dopt%3DAbstract</link>
            <description>We report two cases of hepatocellular carcinoma with prominent lymphocytic infiltration, which has been described as a subtype of hepatocellular carcinoma with good prognosis. One case showed lymphoid follicles and dense lymphocytic infiltrates within the tumor and its periphery, and the other case showed marked lymphocytic infiltration in the cancerous tissue. Piecemeal necrosis of cancer cells and atypical reactive changes were evident. The two cases were seronegative for hepatitis B surface antigen, antibody to hepatitis C virus, and Epstein-Barr virus DNA. One of the cases showed Clonorchis infestation. The prognostic significance of lymphocytic stroma in hepatocellular carcinoma requires further investigation.
    PMID: 18815463 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831524</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831524</guid>        </item>
        <item>
            <title>[Epithelioid hemangioendothelioma of the liver.]</title>
            <link>http://www.medworm.com/index.php?rid=1831523&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815464%26dopt%3DAbstract</link>
            <description>Authors: Kim YB
    
    PMID: 18815464 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831523</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831523</guid>        </item>
        <item>
            <title>[Imaging findings of hepatic adenoma.]</title>
            <link>http://www.medworm.com/index.php?rid=1831522&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815465%26dopt%3DAbstract</link>
            <description>Authors: Han JK, Eun HW, Kim SH
    
    PMID: 18815465 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831522</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831522</guid>        </item>
        <item>
            <title>Entecavir 1 mg therapy for lamivudine-refractory chronic hepatitis B.</title>
            <link>http://www.medworm.com/index.php?rid=1831521&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18815466%26dopt%3DAbstract</link>
            <description>Authors: Kim HJ
    
    PMID: 18815466 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1831521</comments>
            <pubDate>Mon, 01 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1831521</guid>        </item>
        <item>
            <title>[Problems faced by Korean patients with chronic liver disease and the role of the Korean Association for the Study of the Liver--emphases on social discrimination, insufficiency of reimbursement coverage, and deficiency of the welfare system]</title>
            <link>http://www.medworm.com/index.php?rid=1629456&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617759%26dopt%3DAbstract</link>
            <description>Authors: Kim DJ, Kim HS, Yim HJ, Suh JI, Cheong JY, Kim IH, Tark WY, Lee YS, Lee S, Lee JY
    
    PMID: 18617759 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629456</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629456</guid>        </item>
        <item>
            <title>[The relation between hepatic venous pressure gradient and complications of liver cirrhosis]</title>
            <link>http://www.medworm.com/index.php?rid=1629455&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617760%26dopt%3DAbstract</link>
            <description>Authors: Paik YH
    
    PMID: 18617760 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629455</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629455</guid>        </item>
        <item>
            <title>[Physiologic and pathologic experimental models for studying cholangiocytes]</title>
            <link>http://www.medworm.com/index.php?rid=1629454&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617761%26dopt%3DAbstract</link>
            <description>Authors: Lee SO
    Cholangiocytes (epithelial cells lining the intra- and extrahepatic bile ducts) and hepatocytes are two major components of liver epithelia. Although cholangiocytes are less numerous than hepatocytes, they are involved in both bile secretion and diverse cellular processes such as cell-cycle phenomena, cell signaling, and interactions with other cells, matrix components, foreign organisms, and xenobiotics. Cholangiocytes are also targets in several human diseases including cholangiocarcinoma, primary sclerosing cholangitis, autoimmune cholangitis, and vanishing bile-duct syndrome. The rapid advances in experimental biology technologies are greatly expanding interest in and knowledge of the physiology and pathophysiology of cholangiocytes. This review focuses on the progr...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629454</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629454</guid>        </item>
        <item>
            <title>[Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea]</title>
            <link>http://www.medworm.com/index.php?rid=1629453&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617762%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: HVPG was correlated with the severity of liver cirrhosis, presence of ascites, and risk of variceal bleeding in patients with liver cirrhosis.
    PMID: 18617762 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629453</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629453</guid>        </item>
        <item>
            <title>[Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model]</title>
            <link>http://www.medworm.com/index.php?rid=1629452&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617763%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: These results indicate that serum HA is a useful and noninvasive serologic marker for the evaluation of advanced hepatic fibrosis.
    PMID: 18617763 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629452</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629452</guid>        </item>
        <item>
            <title>[Incidence and risk factors of acute renal failure after transcatheter arterial chemoembolization for hepatocellular carcinoma]</title>
            <link>http://www.medworm.com/index.php?rid=1629451&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617764%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The incidence of ARF after TACE was 3.2%, and the presence of ascites and an abnormal baseline serum creatinine level were the risk factors for ARF.
    PMID: 18617764 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629451</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629451</guid>        </item>
        <item>
            <title>[Clinical feature of Fitz-Hugh-Curtis syndrome: analysis of 25 cases]</title>
            <link>http://www.medworm.com/index.php?rid=1629450&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617765%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Symptoms and physical findings suggestive of PID are not present in many patients with Fitz-Hugh-Curtis syndrome. When a premenopausal woman complains of upper abdominal pain and shows CT findings compatible with perihepatitis, examination of cervical discharge would be recommended to assess the possibility of Fitz-Hugh-Curtis syndrome.
    PMID: 18617765 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629450</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629450</guid>        </item>
        <item>
            <title>[Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma]</title>
            <link>http://www.medworm.com/index.php?rid=1629449&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617766%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Our study showed that the expression of VEGF-A is positively correlated with the recurrence rate of HCC after curative resection. Therefore, a high expression of VEGF-A might be predictive of HCC recurrence after curative resection.
    PMID: 18617766 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629449</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629449</guid>        </item>
        <item>
            <title>[Hepatitis B core antigen expression pattern predicts response to lamivudine therapy in patients with chronic hepatitis B]</title>
            <link>http://www.medworm.com/index.php?rid=1629448&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617767%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The expression pattern of HBcAg (including its possible absence) before initial therapy appears to predict the response to antiviral treatment.
    PMID: 18617767 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629448</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629448</guid>        </item>
        <item>
            <title>[Four cases of toxic liver injury associated with Dictamnus dasycarpus]</title>
            <link>http://www.medworm.com/index.php?rid=1629447&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617768%26dopt%3DAbstract</link>
            <description>We report four cases of toxic hepatitis that occurred after taking a decoction made by boiling down the root of Dictamnus dasycarpus. The four patients had a median age of 60 years, common symptoms of jaundice and general weakness, and stated that they had not consumed alcohol for at least 5 years. The markers of hepatitis A, B, and C were all negative in the patients. Abdominal ultrasonography revealed common bile ducts with normal diameters. Two of the cases were a mother and daughter, and the other two were sporadic. All of them had consumed a decoction made by boiling down the root of Dictamnus dasycarpus five or six times daily until several days before admission. Dictamnus dasycarpus induced liver injury presenting with a benign course lasting less than 1 month after cessation of the...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629447</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629447</guid>        </item>
        <item>
            <title>[Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia]</title>
            <link>http://www.medworm.com/index.php?rid=1629446&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617769%26dopt%3DAbstract</link>
            <description>Authors: Lim SM, Jang JW, Kim BW, Choi H, Choi KY, Park SJ, Han CW
    It is generally accepted that seroconversion of hepatitis B virus (HBV) surface antigen (HBsAg) to an antibody to HBsAg (anti-HBs) indicates clearance of HBV. Here we report a case of severe hepatitis that manifested during chemotherapy in a female patient with chronic lymphocytic leukemia (CLL) who had been initially seronegative for HBsAg and seropositive for anti-HBs. The patient received chlorambucil and prednisolone for the treatment of CLL. After 6 months the serum levels of aminotransferases were increased, and HBsAg and HBV DNA were present in serum. Lamivudine was administered immediately after confirming the HBV reactivation, which considerably improved jaundice and aminotransferase levels after 3 weeks. The p...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629446</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629446</guid>        </item>
        <item>
            <title>[Focal nodular hyperplasia-like nodule in liver cirrhosis]</title>
            <link>http://www.medworm.com/index.php?rid=1629445&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617771%26dopt%3DAbstract</link>
            <description>Authors: Kim H, Park YN
    
    PMID: 18617771 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629445</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629445</guid>        </item>
        <item>
            <title>[Radiologic findings of dysplastic nodule]</title>
            <link>http://www.medworm.com/index.php?rid=1629444&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617772%26dopt%3DAbstract</link>
            <description>Authors: Han JK, Eun HW, Kim SH
    
    PMID: 18617772 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629444</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629444</guid>        </item>
        <item>
            <title>[Adefovir plus lamivudine combination therapy in lamivudine-resistant chronic hepatitis B]</title>
            <link>http://www.medworm.com/index.php?rid=1629443&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617773%26dopt%3DAbstract</link>
            <description>Authors: Kwon SY
    
    PMID: 18617773 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1629443</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1629443</guid>        </item>
        <item>
            <title>[Problems faced by Korean patients with chronic liver disease and the role of the Korean Association for the Study of the Liver - Emphases on social discrimination, insufficiency of reimbursement coverage, and deficiency of the welfare system.]</title>
            <link>http://www.medworm.com/index.php?rid=1611832&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617759%26dopt%3DAbstract</link>
            <description>Authors: Kim DJ, Kim HS, Yim HJ, Suh JI, Cheong JY, Kim IH, Tark WY, Lee YS, Lee S, Lee JY
    
    PMID: 18617759 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611832</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611832</guid>        </item>
        <item>
            <title>[The relation between hepatic venous pressure gradient and complications of liver cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=1611831&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617760%26dopt%3DAbstract</link>
            <description>Authors: Paik YH
    
    PMID: 18617760 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611831</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611831</guid>        </item>
        <item>
            <title>[Physiologic and pathologic experimental models for studying cholangiocytes.]</title>
            <link>http://www.medworm.com/index.php?rid=1611830&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617761%26dopt%3DAbstract</link>
            <description>Authors: Lee SO
    Cholangiocytes (epithelial cells lining the intra- and extrahepatic bile ducts) and hepatocytes are two major components of liver epithelia. Although cholangiocytes are less numerous than hepatocytes, they are involved in both bile secretion and diverse cellular processes such as cell-cycle phenomena, cell signaling, and interactions with other cells, matrix components, foreign organisms, and xenobiotics. Cholangiocytes are also targets in several human diseases including cholangiocarcinoma, primary sclerosing cholangitis, autoimmune cholangitis, and vanishing bile-duct syndrome. The rapid advances in experimental biology technologies are greatly expanding interest in and knowledge of the physiology and pathophysiology of cholangiocytes. This review focuses on the progr...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611830</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611830</guid>        </item>
        <item>
            <title>[Measurement of hepatic venous pressure gradient in liver cirrhosis: Relationship with the status of cirrhosis, varices, and ascites in Korea.]</title>
            <link>http://www.medworm.com/index.php?rid=1611829&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617762%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: HVPG was correlated with the severity of liver cirrhosis, presence of ascites, and risk of variceal bleeding in patients with liver cirrhosis.
    PMID: 18617762 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611829</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611829</guid>        </item>
        <item>
            <title>[Serum hyaluronic acid level: Correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model.]</title>
            <link>http://www.medworm.com/index.php?rid=1611828&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617763%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: These results indicate that serum HA is a useful and noninvasive serologic marker for the evaluation of advanced hepatic fibrosis.
    PMID: 18617763 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611828</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611828</guid>        </item>
        <item>
            <title>[Incidence and risk factors of acute renal failure after transcatheter arterial chemoembolization for hepatocellular carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=1611827&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617764%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The incidence of ARF after TACE was 3.2%, and the presence of ascites and an abnormal baseline serum creatinine level were the risk factors for ARF.
    PMID: 18617764 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611827</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611827</guid>        </item>
        <item>
            <title>[Clinical feature of Fitz-Hugh-Curtis syndrome: Analysis of 25 cases.]</title>
            <link>http://www.medworm.com/index.php?rid=1611826&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617765%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Symptoms and physical findings suggestive of PID are not present in many patients with Fitz-Hugh-Curtis syndrome. When a premenopausal woman complains of upper abdominal pain and shows CT findings compatible with perihepatitis, examination of cervical discharge would be recommended to assess the possibility of Fitz-Hugh-Curtis syndrome.
    PMID: 18617765 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611826</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611826</guid>        </item>
        <item>
            <title>[Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma.]</title>
            <link>http://www.medworm.com/index.php?rid=1611825&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617766%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Our study showed that the expression of VEGF-A is positively correlated with the recurrence rate of HCC after curative resection. Therefore, a high expression of VEGF-A might be predictive of HCC recurrence after curative resection.
    PMID: 18617766 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611825</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611825</guid>        </item>
        <item>
            <title>[Hepatitis B core antigen expression pattern predicts response to lamivudine therapy in patients with chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=1611824&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617767%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The expression pattern of HBcAg (including its possible absence) before initial therapy appears to predict the response to antiviral treatment.
    PMID: 18617767 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611824</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611824</guid>        </item>
        <item>
            <title>[Four cases of toxic liver injury associated with Dictamnus dasycarpus.]</title>
            <link>http://www.medworm.com/index.php?rid=1611823&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617768%26dopt%3DAbstract</link>
            <description>We report four cases of toxic hepatitis that occurred after taking a decoction made by boiling down the root of Dictamnus dasycarpus. The four patients had a median age of 60 years, common symptoms of jaundice and general weakness, and stated that they had not consumed alcohol for at least 5 years. The markers of hepatitis A, B, and C were all negative in the patients. Abdominal ultrasonography revealed common bile ducts with normal diameters. Two of the cases were a mother and daughter, and the other two were sporadic. All of them had consumed a decoction made by boiling down the root of Dictamnus dasycarpus five or six times daily until several days before admission. Dictamnus dasycarpus induced liver injury presenting with a benign course lasting less than 1 month after cessation of the...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611823</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611823</guid>        </item>
        <item>
            <title>[Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia.]</title>
            <link>http://www.medworm.com/index.php?rid=1611822&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617769%26dopt%3DAbstract</link>
            <description>Authors: Lim SM, Jang JW, Kim BW, Choi H, Choi KY, Park SJ, Han CW
    It is generally accepted that seroconversion of hepatitis B virus (HBV) surface antigen (HBsAg) to an antibody to HBsAg (anti-HBs) indicates clearance of HBV. Here we report a case of severe hepatitis that manifested during chemotherapy in a female patient with chronic lymphocytic leukemia (CLL) who had been initially seronegative for HBsAg and seropositive for anti-HBs. The patient received chlorambucil and prednisolone for the treatment of CLL. After 6 months the serum levels of aminotransferases were increased, and HBsAg and HBV DNA were present in serum. Lamivudine was administered immediately after confirming the HBV reactivation, which considerably improved jaundice and aminotransferase levels after 3 weeks. The p...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611822</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611822</guid>        </item>
        <item>
            <title>An adult case of glycogen storage disease type IIIa.</title>
            <link>http://www.medworm.com/index.php?rid=1611821&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617770%26dopt%3DAbstract</link>
            <description>We report a rare case of GSD III in an adult. A 52-year-old woman presented to our clinic due to dyspnea on exertion, severe general weakness, and hepatomegaly. Hypertrophic cardiomyopathy was diagnosed based on echocardiogram findings. The microscopic findings of liver and skeletal muscle biopsies were consistent with the diagnosis of GSD. DNA analysis prompted by clinical and pathologic findings led to a definitive diagnosis of GSD IIIa. Diet therapy with cornstarch was started, and the patient was followed closely. This represents the first reported case of GSD IIIa diagnosed in an adult in Korea.
    PMID: 18617770 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611821</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611821</guid>        </item>
        <item>
            <title>[Focal nodular hyperplasia-like nodule in liver cirrhosis.]</title>
            <link>http://www.medworm.com/index.php?rid=1611820&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617771%26dopt%3DAbstract</link>
            <description>Authors: Kim H, Park YN
    
    PMID: 18617771 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611820</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611820</guid>        </item>
        <item>
            <title>[Radiologic findings of dysplastic nodule.]</title>
            <link>http://www.medworm.com/index.php?rid=1611819&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617772%26dopt%3DAbstract</link>
            <description>Authors: Han JK, Eun HW, Kim SH
    
    PMID: 18617772 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611819</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611819</guid>        </item>
        <item>
            <title>[Adefovir plus lamivudine combination therapy in lamivudine-resistant chronic hepatitis B.]</title>
            <link>http://www.medworm.com/index.php?rid=1611818&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18617773%26dopt%3DAbstract</link>
            <description>Authors: Kwon SY
    
    PMID: 18617773 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1611818</comments>
            <pubDate>Sun, 01 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1611818</guid>        </item>
        <item>
            <title>[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease]</title>
            <link>http://www.medworm.com/index.php?rid=1553843&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367852%26dopt%3DAbstract</link>
            <description>Authors: Kim MY, Baik SK
    
    PMID: 18367852 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553843</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553843</guid>        </item>
        <item>
            <title>[Recent developments in systemic chemotherapy for hepatocellular carcinoma]</title>
            <link>http://www.medworm.com/index.php?rid=1553842&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367853%26dopt%3DAbstract</link>
            <description>Authors: Han CJ
    Despite recent developments in various chemotherapeutic agents and the performing of numerous clinical trials, chemotherapy still produces unsatisfactory results in hepatocellular carcinoma due to poor clinical benefit compared with untreated controls and its significant toxicity. The presence of liver cirrhosis, its complications, and decreased liver function increase the complexity of chemotherapy. There is recent evidence that targeted agents and antiangiogenic agents such as thalidomide are somewhat effective whilst having minimal toxicities. Some patients are cured by aggressive chemotherapy alone or in combination with other modalities. Therefore, if a patient is in good condition and the tumor shows some response to chemotherapy, aggressive chemotherapy might be ...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553842</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553842</guid>        </item>
        <item>
            <title>[Nonalcoholic steatohepatitis: pathogenesis and treatment]</title>
            <link>http://www.medworm.com/index.php?rid=1553841&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367854%26dopt%3DAbstract</link>
            <description>Authors: Park SH
    Nonalcoholic fatty liver disease (NAFLD) is characterized by a wide spectrum of liver damage spanning steatosis, nonalcoholic steatohepatitis (NASH), cryptogenic liver cirrhosis, and even to hepatocellular carcinoma. Investigations in the last few years have focused on NASH, a relatively aggressive form of liver disease, due largely to the explosion of information provided by clinical and basic science studies related to the widespread presence of risk factors, such as obesity, type II diabetes mellitus, and dyslipidemia. This is especially important given that obesity and type II diabetes mellitus have recently reached epidemic proportions in Korea. The pathogenesis of NASH is multifactorial, with insulin resistance and increased fatty acid possibly being important fa...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553841</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553841</guid>        </item>
        <item>
            <title>[Distribution of hepatitis C virus genotypes in Jeju Island]</title>
            <link>http://www.medworm.com/index.php?rid=1553840&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367855%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: HCV genotype 2a is most common in Jeju, followed by genotype 1b. Our results suggest that the distribution of the HCV genotype differs between regions in Korea.
    PMID: 18367855 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553840</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553840</guid>        </item>
        <item>
            <title>[Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C]</title>
            <link>http://www.medworm.com/index.php?rid=1553839&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367856%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: This study shows that a combination therapy of peginterferon and ribavirin is highly effective for chronic HCV infection, producing a high SVR and ETR.
    PMID: 18367856 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553839</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553839</guid>        </item>
        <item>
            <title>[Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C]</title>
            <link>http://www.medworm.com/index.php?rid=1553838&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367857%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: The rate of SVRs in Korean patients with chronic hepatitis C was higher for combined PEG-IFN and ribavirin than for combined IFN-alpha and ribavirin. Further study is needed to clarify the outcome of short-term therapy in patients with a rapid or early virological response.
    PMID: 18367857 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553838</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553838</guid>        </item>
        <item>
            <title>[Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients]</title>
            <link>http://www.medworm.com/index.php?rid=1553837&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367858%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Lamivudine-resistant HBV patients exhibiting HBeAg negativity and liver cirrhosis were more likely to achieve an IVR after adefovir therapy. Adefovir resistance was associated with mixed infection of the precore mutant.
    PMID: 18367858 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553837</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553837</guid>        </item>
        <item>
            <title>[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]</title>
            <link>http://www.medworm.com/index.php?rid=1553836&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367859%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Anti-HBc positivity is not a risk factor for HCC. However, occult HBV infection may be a risk factor for HCC in patients with alcoholic LC.
    PMID: 18367859 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553836</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553836</guid>        </item>
        <item>
            <title>[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]</title>
            <link>http://www.medworm.com/index.php?rid=1553835&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367860%26dopt%3DAbstract</link>
            <description>CONCLUSIONS: Patients with NAFLD are at a high risk of carotid atherosclerosis regardless of metabolic syndrome and classical cardiovascular risk factors. Therefore, the detection of NAFLD should alert to the existence of an increased cardiovascular risk. Moreover, NAFLD might be an independent risk factor for cardiovascular disease.
    PMID: 18367860 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553835</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553835</guid>        </item>
        <item>
            <title>[A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis]</title>
            <link>http://www.medworm.com/index.php?rid=1553834&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367862%26dopt%3DAbstract</link>
            <description>Authors: Yoon JY, Min SY, Park JY, Hong SG, Park SJ, Paik SY, Park YM
    Allopurinol-induced hypersensitivity syndrome is characterized by an idiosyncratic reaction involving multiple-organs, which usually begins 2 to 6 weeks after starting allopurinol. In rare cases, the adverse reactions to allopurinol are accompanied by a variety of liver injury, such as reactive hepatitis, granulomatous hepatitis, vanishing bile duct syndrome, or fulminant hepatic failure. Here we report a case with granulomatous hepatitis and ductopenia. A 69-year-old man with chronic renal failure, hyperuricemia, and previously normal liver function presented with jaundice, skin rash, and fever 2 weeks after taking allopurinol (200 mg/day). In histopathology, a liver biopsy specimen showed mild spotty necrosis of he...</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553834</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553834</guid>        </item>
        <item>
            <title>[A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia]</title>
            <link>http://www.medworm.com/index.php?rid=1553833&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367863%26dopt%3DAbstract</link>
            <description>Authors: Lee JY, Park EB, Ahn JH, Suh SJ, Jung YK, Kim JH, Shin BK, Yang JH, Yeon JE, Byun KS
    Ticlopidine inhibits platelet aggregation and provides beneficial secondary prevention of cerebrovascular and coronary artery disease. Frequently reported adverse effects of ticlopidine include diarrhea, nausea, and rash. However, to our knowledge, there are only a few published reports of the simultaneous occurrence of cholestatic hepatitis and pure red cell aplasia. Here we report a patient with simultaneous severe cholestatic hepatitis and pure red cell aplasia associated with ticlopidine. Although these adverse effects are rare, periodic hematological and liver function tests are recommended after starting ticlopidine.
    PMID: 18367863 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553833</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553833</guid>        </item>
        <item>
            <title>[Hepatic adenomatosis in glycogen storage disease]</title>
            <link>http://www.medworm.com/index.php?rid=1553832&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367864%26dopt%3DAbstract</link>
            <description>Authors: Kwon JE, Park YN
    
    PMID: 18367864 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553832</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553832</guid>        </item>
        <item>
            <title>[Angiomyolipoma]</title>
            <link>http://www.medworm.com/index.php?rid=1553831&amp;cid=s_30410_17_f&amp;fid=30410&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D18367865%26dopt%3DAbstract</link>
            <description>Authors: Lee WJ
    
    PMID: 18367865 [PubMed - in process] (Source: Korean J Hepatol)</description>
            <author>Korean J Hepatol</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1553831</comments>
            <pubDate>Sat, 01 Mar 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1553831</guid>        </item>
    </channel>
</rss>
